The GOLD International COPD Conference will cover underdiagnosis, exacerbations, mucus, biologics, and a preview of the 2027 GOLD Report.
Publication|Articles|November 2, 2026
Supplements and Featured Publications
- Self-Administered Treatment in Paroxysmal Supraventricular Tachycardia (PSVT): Clinical and Payer Considerations With CARDAMYST® (Etripamil)
Self-Administered Treatment in Paroxysmal Supraventricular Tachycardia (PSVT): Clinical and Payer Considerations With CARDAMYST® (Etripamil)
This publication was sponsored by Milestone Pharmaceuticals, Inc.
Advertisement
This clinical brief reviews the disease burden and treatment landscape of paroxysmal supraventricular tachycardia, summarizes phase 3 efficacy and safety data supporting CARDAMYST®, and highlights key payer and economic considerations.
Advertisement
Related to this article
People with multiple sclerosis make up most of a survey linking variable-friction footwear to fewer self-reported falls.
Clinicians at an AJMC roundtable in Cleveland said Medicare's GLP-1 Bridge came late and that cost and capacity gaps persist.
Nathan Estrada, DPT, explains which patients, including those with multiple sclerosis, may benefit from footwear that adapts to gait.
Patients with Sjögren disease have 5-fold higher odds of depression, yet screening tools remain unvalidated, a new review finds.
Medicare Advantage exits, rising ACA premiums, a Medicare for America bill, and a Medicaid work rule ruling frame health policy on Election Day.
Patient selection raised detection of pathogenic germline variants from 6% to 27% in lung cancer studies.
Pharmacists outline new oncologic therapeutics, from pancreatic cancer to myeloma, and what high prices and crowded markets mean for payers.
Advertisement
Advertisement
Trending on AJMC
1
First-Line Vitiligo Treatment: Topical JAK Inhibitors and Phototherapy
2
Multidisciplinary Care for Vitiligo: Beyond Dermatology
3
GLP-1 Use Tied to Lower Diabetes, CV Risk vs Metformin in Prediabetes
4
Invivyd Unveils Measles Antibody Candidate VMS063 at IDWeek 2026
5